MA49520A - Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation - Google Patents

Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation

Info

Publication number
MA49520A
MA49520A MA049520A MA49520A MA49520A MA 49520 A MA49520 A MA 49520A MA 049520 A MA049520 A MA 049520A MA 49520 A MA49520 A MA 49520A MA 49520 A MA49520 A MA 49520A
Authority
MA
Morocco
Prior art keywords
silk
methods
hyaluronic acid
tissue fillers
acid tissue
Prior art date
Application number
MA049520A
Other languages
English (en)
Inventor
Gregory H Altman
Erlei Jin
Peng Xu
Original Assignee
Evolved By Nature Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolved By Nature Inc filed Critical Evolved By Nature Inc
Publication of MA49520A publication Critical patent/MA49520A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA049520A 2017-06-26 2018-06-26 Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation MA49520A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762525131P 2017-06-26 2017-06-26
US201862641095P 2018-03-09 2018-03-09

Publications (1)

Publication Number Publication Date
MA49520A true MA49520A (fr) 2021-04-14

Family

ID=64742709

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049520A MA49520A (fr) 2017-06-26 2018-06-26 Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation

Country Status (14)

Country Link
US (1) US20230338614A1 (fr)
EP (2) EP3645063B1 (fr)
JP (2) JP2020525253A (fr)
KR (1) KR20200032103A (fr)
CN (1) CN111263646A (fr)
AU (1) AU2018290810B2 (fr)
CA (1) CA3068296A1 (fr)
CO (1) CO2020000774A2 (fr)
ES (1) ES2935887T3 (fr)
IL (2) IL299584A (fr)
MA (1) MA49520A (fr)
SG (1) SG11201913229PA (fr)
UA (1) UA127350C2 (fr)
WO (1) WO2019005848A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190997A1 (en) 2017-06-26 2023-06-22 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue filers and methods of using the same
CN111032930B (zh) 2017-09-21 2024-01-02 住友电气工业株式会社 半绝缘性砷化镓晶体基板
US20230114250A1 (en) * 2018-12-19 2023-04-13 Evolved By Nature, Inc. Silk-hyaluronic acid tissue fillers and methods of making and using the same
WO2020205774A1 (fr) * 2019-03-29 2020-10-08 Trustees Of Tufts College Compositions à base de fibroïnes de soie, ses procédés de préparation et ses méthodes d'utilisation
EP3979873A4 (fr) * 2019-06-06 2023-08-16 Evolved by Nature, Inc. Production de collagène stimulée par la soie et procédés d'utilisation de celle-ci
WO2020262596A1 (fr) * 2019-06-26 2020-12-30 Compagnie Generale Des Etablissements Michelin Bande de roulement réduisant le bruit
CN110339398A (zh) * 2019-07-18 2019-10-18 王月玲 一种含氨基酸透明质酸钠注射剂及其制备方法
WO2021035087A1 (fr) * 2019-08-20 2021-02-25 Evolved By Nature, Inc. Compositions de soins personnels à base de soie
WO2021060934A1 (fr) * 2019-09-27 2021-04-01 주식회사 엘지화학 Procédé de préparation de microparticules polymères, microparticules polymères, composition médicale les comprenant, composition cosmétique, article médical et article cosmétique
WO2021123247A1 (fr) * 2019-12-19 2021-06-24 Croma-Pharma Gmbh Hyaluronane modifié par thiol et hydrogel comprenant l'hyaluronane réticulé
EP4167949A4 (fr) * 2020-06-19 2024-05-15 Evolved by Nature, Inc. Compositions de soie-acide hyaluronique pour le remplissage tissulaire, l'espacement tissulaire et le gonflement tissulaire
EP4149277A1 (fr) 2021-05-21 2023-03-22 Cambridge Crops, Inc. d/b/a Mori Systèmes et procédés de fabrication d'une solution de fibroïne de soie et poudres contenant de la fibroïne de soie
EP4362993A1 (fr) * 2021-06-30 2024-05-08 Merz Pharma GmbH & Co. KGaA Charges dermiques d'acide hyaluronique réticulées avec de l'éther diglycidique de glycol polyéthylénique, leur procédé de fabrication et leurs utilisations
CN113368220A (zh) * 2021-07-05 2021-09-10 云南维他源生物科技有限公司 一种ahco组合物及其制剂与应用
KR20230013682A (ko) 2021-07-16 2023-01-27 주식회사 휴메딕스 Pegde로 가교된 히알루론산 필러 및 이의 제조방법
US11864569B2 (en) 2021-08-16 2024-01-09 Cambridge Crops, Inc. Systems and methods for improving the performance of cereal using a silk fibroin solution and powders containing silk fibroin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH564031A5 (fr) 1968-03-29 1975-07-15 Anvar
FR2334107A1 (fr) 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
US4355023A (en) 1980-09-30 1982-10-19 The Massachusetts General Hospital Antibody fragment compositions and process
US4657853A (en) 1984-09-14 1987-04-14 E. I. Du Pont De Nemours And Company Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US20110189292A1 (en) 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
WO2011059325A2 (fr) * 2009-11-11 2011-05-19 University Of Twente, Institute For Biomedical Technology And Technical Medicine (Mira) Hydrogels à base de dextrane et d'acide hyaluronique
EP3536307B1 (fr) * 2011-06-03 2021-10-20 ALLERGAN Industrie, SAS Compositions de remplissage dermique comprenant des antioxydants
RU2626513C2 (ru) * 2011-09-14 2017-07-28 Аллерган, Инк. Композиции кожного наполнителя для лечения мелких морщин
CN102836465B (zh) * 2012-08-30 2014-06-04 浙江星月生物科技股份有限公司 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用
WO2014055895A1 (fr) * 2012-10-05 2014-04-10 Allergan, Inc. Dispositif injectable et méthode de modelage, d'augmentation ou de correction de traits faciaux tels que du menton
US20140315828A1 (en) * 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
US10077320B2 (en) 2013-06-28 2018-09-18 Galderma S.A. Process for preparing a cross-linked hyaluronic acid product
BR112016006898A8 (pt) 2013-09-30 2020-02-18 Silk Therapeutics Inc composição, filmes, método de redução de linhas finas e rugas, géis, método de suavização e rejuvenescimento da pele humana, soro, método de hidratação da pele humana, composição de descamação da pele e método para a preparação de uma solução
JP6946187B2 (ja) 2014-12-02 2021-10-06 エボルブド バイ ネイチャー， インコーポレイテッド シルク性能衣服及び製品、並びにこれらを製造する方法
JP7290912B2 (ja) * 2015-04-29 2023-06-14 エボルブド バイ ネイチャー， インコーポレイテッド 絹ベース湿潤剤組成物、及びその方法
US10175996B2 (en) 2016-05-02 2019-01-08 Norman R. Byrne Information display and control for work areas
WO2018039496A1 (fr) * 2016-08-24 2018-03-01 Allergan, Inc. Hydrogels co-réticulés d'acide hyaluronique-fibroïne pour améliorer la viabilité des greffes tissulaires et pour l'augmentation des tissus mous

Also Published As

Publication number Publication date
UA127350C2 (uk) 2023-07-26
JP2020525253A (ja) 2020-08-27
EP3645063B1 (fr) 2022-09-28
JP2023139249A (ja) 2023-10-03
EP3645063A4 (fr) 2021-04-14
BR112019027687A2 (pt) 2020-09-15
AU2018290810B2 (en) 2024-06-13
IL271692B2 (en) 2023-06-01
EP3645063A1 (fr) 2020-05-06
US20230338614A1 (en) 2023-10-26
KR20200032103A (ko) 2020-03-25
ES2935887T3 (es) 2023-03-13
CN111263646A (zh) 2020-06-09
EP4169539A1 (fr) 2023-04-26
IL299584A (en) 2023-03-01
SG11201913229PA (en) 2020-01-30
AU2018290810A1 (en) 2020-02-13
IL271692A (en) 2020-02-27
CA3068296A1 (fr) 2019-01-03
WO2019005848A1 (fr) 2019-01-03
CO2020000774A2 (es) 2020-05-05

Similar Documents

Publication Publication Date Title
MA49520A (fr) Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation
MA45280A (fr) Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation
MA49950A (fr) Anticorps anti-b7-h4 et leurs procédés d'utilisation
MA44740A (fr) Variantes de capsides de virus adéno-associé et leurs procédés d'utilisation
MA50077A (fr) Inhibiteurs de kras g12c et leurs procédés d'utilisation
MA47499A (fr) Anticorps anti-tau et leurs procédés d'utilisation
MA44490A (fr) Adhésifs biocompatibles et leurs procédés d'utilisation
MA55136A (fr) Inhibiteurs de kras g12c et leurs procédés d'utilisation
MA48772A (fr) Inhibiteurs de kras g12c et leurs procédés d'utilisation
MA55890A (fr) Modulateurs de thr-beta et leurs procédés d'utilisation
MA46566A (fr) Oxystérols et leurs procédés d'utilisation
MA52753A (fr) Anticorps anti-sirpa et leurs procédés d'utilisation
MA44524A (fr) Néoantigènes et leurs procédés d'utilisation
MA46565A (fr) Oxystérols et leurs procédés d'utilisation
MA55097A (fr) Oxystérols et leurs procédés d'utilisation
MA42043A (fr) Anticorps anti-ox40 et procédés d'utilisation de ceux-ci
MA49045A (fr) Compositions et procédés destinés à la distribution régulée d'acide
MA41999A (fr) Compositions d'acide obéticholique et procédés d'utilisation
MA54594A (fr) Stéroïdes neuroactifs et leurs procédés d'utilisation
MA50956A (fr) Anticorps anti-cd137 et procédés d'utilisation correspondants
MA54538A (fr) Inhibiteurs d'apol1 et leurs procédés d'utilisation
MA48709A (fr) Conjugués de médicament à base de silicium et leurs procédés d'utilisation
MA54851A (fr) Oxystérols et leurs procédés d'utilisation
MA42409A (fr) Oxystérols et leurs procédés d'utilisation
MA45290A (fr) Procédés et compositions d'agents biologiquement actifs